Apixaban Versus Warfarin for Left Ventricular Thrombus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 218 participants.
Also called NCT07709780
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 218 participants
- Sponsor
- Registry
-
NCT07709780
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07709780. Randomized; no masking; primary purpose treatment. Start 2026-06-22 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Apixaban Versus Warfarin for Left Ventricular Thrombus
- Acronym
- APEX
- Condition
- Left Ventricular Thrombus
- Intervention (Drug)
- Apixaban
- Intervention (Drug)
- Warfarin
- Lead sponsor
- University of Arizona
Record details
- Record id
cardio:ct-nct07709780- Content hash
9ec7e029943ef43ab79de008886d93b63cdab385b27b11345aefb03e6b6194d7